A novel injectable approach for cartilage formation in vivo using PLG microspheres.
This study documents the use of biodegradable poly(lactide-co-glycolide) (PLG) microspheres as a novel, injectable scaffold for cartilage tissue engineering. Chondrocytes were delivered via injection to the subcutaneous space of athymic mice in the presence and absence of PLG microspheres. Tissue formation was evaluated up to 8 weeks post-injection. Progressive cartilage formation was observed in samples containing microspheres. The presence of microspheres increased the quantity of tissue formed, the amount of glycosaminoglycan that accumulated, and the uniformity of type II collagen deposition. Microsphere composition influenced the growth of the tissue engineered cartilage. Higher molecular weight PLG resulted in a larger mass of cartilage formed and a higher content of proteoglycans. Microspheres comprised PLG with methyl ester end groups yielded increased tissue mass and matrix accumulation, but did not display homogenous matrix deposition. The microencapsulation of Mg(OH)2 had negative effects on tissue mass and matrix accumulation. Matrix accumulation, cell number, and tissue mass were unchanged by microsphere size, but larger microspheres increased the frequency of central necrosis in implants. The data herein reflect the promising utility of an injectable PLG-chondrocyte system for tissue engineering applications.
Mercier
Nichole R
NR
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA.
Costantino
Henry R
HR
Tracy
Mark A
MA
Bonassar
Lawrence J
LJ
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry; D002358:Cartilage, Articular / Q000166:cytology / Q000254:growth & development* / Q000637:transplantation*; D002417:Cattle; D002455:Cell Division; D002470:Cell Survival; D017690:Cell Transplantation / Q000295:instrumentation / Q000379:methods*; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000502:physiology / Q000637:transplantation*; D005240:Feasibility Studies; D006016:Glycolates / Q000737:chemistry*; D006025:Glycosaminoglycans / Q000378:metabolism; D007267:Injections / Q000379:methods; D019344:Lactic Acid; D008422:Materials Testing; D051379:Mice; D008863:Microspheres; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D023822:Tissue Engineering / Q000379:methods*
D001672:Biocompatible Materials; D006016:Glycolates; D006025:Glycosaminoglycans; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid